Vishnu Mohanan

445 total citations
10 papers, 317 citations indexed

About

Vishnu Mohanan is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Vishnu Mohanan has authored 10 papers receiving a total of 317 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Vishnu Mohanan's work include Immune Response and Inflammation (3 papers), Inflammatory Bowel Disease (3 papers) and Autophagy in Disease and Therapy (2 papers). Vishnu Mohanan is often cited by papers focused on Immune Response and Inflammation (3 papers), Inflammatory Bowel Disease (3 papers) and Autophagy in Disease and Therapy (2 papers). Vishnu Mohanan collaborates with scholars based in United States and Canada. Vishnu Mohanan's co-authors include Catherine L. Grimes, Ramnik J. Xavier, Kara G. Lassen, Murali K. Temburni, John C. Kappes, Deni S. Galileo, James E. Melnyk, Geraldine L. C. Paulus, Gautam Goel and Jason S. Rush and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Vishnu Mohanan

10 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vishnu Mohanan United States	7	195	108	89	54	33	10	317
Anika Reinhardt Germany	10	229 1.2×	46 0.4×	50 0.6×	93 1.7×	31 0.9×	15	389
Maitreyi S. Rajala India	11	125 0.6×	82 0.8×	107 1.2×	88 1.6×	18 0.5×	20	319
Takashi Ohkura Japan	9	175 0.9×	112 1.0×	160 1.8×	21 0.4×	58 1.8×	11	340
Cécile Gautier France	7	200 1.0×	149 1.4×	75 0.8×	52 1.0×	30 0.9×	11	394
Thorbjorg Einarsdottir Iceland	9	253 1.3×	68 0.6×	77 0.9×	104 1.9×	8 0.2×	12	412
Divyendu Singh United States	10	217 1.1×	244 2.3×	138 1.6×	33 0.6×	17 0.5×	10	481
Rosa T. Sterk United States	7	248 1.3×	50 0.5×	125 1.4×	35 0.6×	32 1.0×	9	395
Emilie Gobbo France	9	191 1.0×	100 0.9×	34 0.4×	31 0.6×	69 2.1×	15	369
Andriy V. Kubarenko Germany	16	326 1.7×	359 3.3×	103 1.2×	67 1.2×	25 0.8×	17	622
Siau‐Kun Bai France	7	263 1.3×	114 1.1×	40 0.4×	41 0.8×	133 4.0×	7	459

Countries citing papers authored by Vishnu Mohanan

Since Specialization

Citations

This map shows the geographic impact of Vishnu Mohanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vishnu Mohanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vishnu Mohanan more than expected).

Fields of papers citing papers by Vishnu Mohanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vishnu Mohanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vishnu Mohanan. The network helps show where Vishnu Mohanan may publish in the future.

Co-authorship network of co-authors of Vishnu Mohanan

This figure shows the co-authorship network connecting the top 25 collaborators of Vishnu Mohanan. A scholar is included among the top collaborators of Vishnu Mohanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vishnu Mohanan. Vishnu Mohanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Jones, Nicholas S., Smita Kshirsagar, Vishnu Mohanan, et al.. (2023). A phase I, randomized, ascending‐dose study to assess safety, pharmacokinetics, and activity of GDC‐8264, a RIP1 inhibitor, in healthy volunteers. Clinical and Translational Science. 16(10). 1997–2009. 12 indexed citations

Varma, Mukund, Motohiko Kadoki, Ariel Lefkovith, et al.. (2020). Cell Type– and Stimulation-Dependent Transcriptional Programs Regulated by Atg16L1 and Its Crohn's Disease Risk Variant T300A. The Journal of Immunology. 205(2). 414–424. 6 indexed citations

Mohanan, Vishnu, Toru Nakata, A. Nicole Desch, et al.. (2018). C1orf106 is a colitis risk gene that regulates stability of epithelial adherens junctions. Science. 359(6380). 1161–1166. 78 indexed citations

Wastyk, Hannah C., et al.. (2017). Crohn’s Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70. Biochemistry. 56(34). 4445–4448. 4 indexed citations

Heath, Robert J. W., Gautam Goel, Leigh A. Baxt, et al.. (2016). RNF166 Determines Recruitment of Adaptor Proteins during Antibacterial Autophagy. Cell Reports. 17(9). 2183–2194. 77 indexed citations

Mohanan, Vishnu, et al.. (2015). Identification and biological consequences of theO-GlcNAc modification of the human innate immune receptor, Nod2. Glycobiology. 26(1). cwv076–cwv076. 19 indexed citations

Melnyk, James E., et al.. (2015). Peptidoglycan Modifications Tune the Stability and Function of the Innate Immune Receptor Nod2. Journal of the American Chemical Society. 137(22). 6987–6990. 46 indexed citations

Grimes, Catherine L. & Vishnu Mohanan. (2015). Rescuing Nod2, an innate immune receptor of bacterial cell wall fragments, in Crohn Disease. The FASEB Journal. 29(S1). 1 indexed citations

Mohanan, Vishnu & Catherine L. Grimes. (2014). The Molecular Chaperone HSP70 Binds to and Stabilizes NOD2, an Important Protein Involved in Crohn Disease. Journal of Biological Chemistry. 289(27). 18987–18998. 32 indexed citations

10.

Mohanan, Vishnu, Murali K. Temburni, John C. Kappes, & Deni S. Galileo. (2012). L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor. Clinical & Experimental Metastasis. 30(4). 507–520. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact